ArticlePDF Available

Optimal Blood Pressure in Preterm Infants

Authors:

Abstract and Figures

Many neonatologists routinely treat infants whose mean arterial blood pressure in mm Hg is less than their gestational age in weeks (GA) but there is uncertainty regarding diagnosis and treatment of hypotension. This addresses the definition of permissive hypotension based on the principles of cardiovascular physiology, and reviews the tools available at the bedside to examine the complex relationship among blood pressure, systemic organ blood flow, and tissue oxygen delivery and oxygen demand in preterm infants (skin color, capillary refill time, urine output, serum lactate level, and acidosis). Importantly, absolute blood pressure values are only one indicator of circulatory status and this review confirms that a mean blood pressure less than gestational age in weeks alone is not a predictor of poor outcome. Global assessment of cardiovascular status and intervention for hypotension restricted to infants with poor perfusion may be associated with good clinical outcomes and should be further evaluated.
Content may be subject to copyright.
Abstract
Many neonatologists routinely treat infants whose mean arterial blood pressure
in mm Hg is less than their gestational age in weeks (GA) but there is uncertainty
regarding diagnosis and treatment of hypotension. This addresses the definition
of permissive hypotension based on the principles of cardiovascular physiology,
and reviews the tools available at the bedside to examine the complex relationship
among blood pressure, systemic organ blood ow, and tissue oxygen delivery and
oxygen demand in preterm infants (skin color, capillary refill time, urine output,
serum lactate level, and acidosis). Importantly, absolute blood pressure values are
only one indicator of circulatory status and this review conrms that a mean blood
pressure less than gestational age in weeks alone is not a predictor of poor outcome.
Global assessment of cardiovascular status and intervention for hypotension restricted
to infants with poor perfusion may be associated with good clinical outcomes and
should be further evaluated.
Key Words: Hypotension, Preterm infant, Systemic blood ow, Echocardiography
INTRODUCTION
Hypotension is a commonly diagnosed and treated complication in preterm infants, but
enormous variation in diagnosis, management, and clinical practice has been documented
1)
.
In extremely low gestational age newborns, the majority of neonatologists (73%) defines
hypotension as a mean blood pressure in mmHg less than the gestational age in weeks
2)
. The
majority (85%) uses volume administration as the initial intervention and dopamine is the
inotrope most commonly used initially (80% of cases)
1,3)
. If the initial inotrope therapy fails,
dobutamine is the most popular second-line therapy (28% of cases)
4)
.
In preterm infants during the first days of life, there is a poor association between blood
pressure and systemic blood flow, with some data even showing an inverse correlation in
the rst hours after birth
5)
. Low superior vena cava (SVC) ow is a risk factor for mortality and
morbidity in preterm infants, but hypotension itself is not reliable in detecting low systemic
blood flow
6-8)
. Functional echocardiography allows assessment of cardiovascular status,
including measurement of systemic blood ow in preterm infants
9)
.
Received: 18 April 2014
Revised: 26 April 2014
Accepted: 28 April 2014
Correspondence to:
Hyun-Kyung Park, M.D., Ph.D.
Department of Pediatrics, Hanyang
University College of Medicine,
17 Haengdang-dong, Seongdong-
gu, Seoul 133-792, Korea
Tel: +82-2-2290-8397
Fax: +82-2-2297-2380
E-mail: neopark@hanyang.ac.kr
Review Article
Optimal Blood Pressure in Preterm Infants
Hyun-Kyung Park, M.D., Ph.D.
Department of Pediatrics, Hanyang University College of Medicine, Seoul, Korea
Neonatal Med 2014 May;21(2):99-105
http://dx.doi.org/10.5385/nm.2014.21.2.99
pISSN 2287-9412 . eISSN 2287-9803
Copyright(c)
By Korean Society of Neonatology.
All right reserved.
This is an Open-Access article distributed
under the terms of the Creative Commons
Attribution Non-Commercial License
(http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted
non-commercial use, distribution, and
repro duction in any medium, provided the
original work is properly cited.
100
Hyun-Kyung Park
Hypotension in Preterm Infants
Without understanding the underlying cardiovascular prin-
ciples of transition, appropriate interventional trials cannot be
designed. erefore, more comprehensive monitoring and assess-
ment of systemic blood flow and tissue oxygenation must be
explored in preterm infants.
DEFINITION OF HYPOTENSION IN PERTERM
INFANTS
Hypotension is defined in clinical trials and in practice as any
value that falls below the fth or tenth percentile for gestational and
postnatal age, respectively
2)
. Although acceptable blood pressure
ranges are not known for the extremely low birth weight (ELBW)
infant, many neonatologists routinely treat infants whose mean
arterial blood pressure is less than their gestational age in weeks
10)
.
Hypotension occurs in approximately 50% of very low birth
weight infants admitted to the intensive care unit. Three levels
of compromised cerebral blood flow (CBF) may also be used to
dene hypotension (Figure 1)
2,11)
. Furthermore, the absolute blood
pressure values at which these thresholds occur are ill-defined
and likely to vary among individual patients and the underlying
pathological processes. us, the clinical denition of hypotension
and a selected group such as very preterm infants (not the phy
-
siological denition itself) should be considered (Figure 1)
2)
.
We do not know the mean arterial blood pressure value at
which cerebrovascular autoregulation is lost in the preterm infant,
although recent studies suggest that it may be as high as 28 to 30
mmHg even in ELBW infants
12)
. There is an association between
the loss of autoregulation, the resultant CBF fluctuations, and
morbidity and mortality in preterm infants
13)
.
In animal models, the ischemic blood pressure threshold is
reached when the corresponding CBF is approximately 50% of the
resting CBF
14)
. However, the “ischemic blood pressure threshold” is
unknown in preterm neonates and is likely to vary with the level of
maturity, intercurrent or pre-existing patho
physiological conditions
and physiological variables such as pH, PaCO
2
, and PaO
2
.
ASSESSMENT OF HEMODYNAMICS BY
ECHOCARDIOGRAPHY
The use of functional echocardiography in recent prospective
clinical trials has contributed to our better understanding of the
hemodynamic changes associated with postnatal transition
2,14)
.
Although there is no evidence that its use is associated with
better outcomes, it provides a more accurate assessment of the
pathophysiology of cardiovascular compromise and is likely
to become an essential part of the hemodynamic evaluation of
preterm infants (Table 1)
15)
.
The left ventricular (LV) ejection fraction (EF) and fractional
shortening (FS) are commonly used to estimate LV systolic
function, although EF and FS are largely influenced by preload,
afterload, and heart rate
15)
. Thus, these load-dependent indices
cannot be reliably used to evaluate cardiac function in the unstable
circulation of infants shortly after birth. Instead, an index known
as the “stress-velocity relationship” has been used clinically for ill
infants as a sensitive and relatively load-independent index. This
index is calculated from the end-systolic wall stress (ESWS), which
is an index of LV afterload, and the LV rate-corrected mean velocity
of circumferential fiber shortening (mVcfc), which is an index of
LV pump function. ESWS is calculated from blood pressure values
and LV dimensions by echocardiographic mea
surement, and
mVcfc is calculated from the LV FS, ejection time, and heart rate
(Table 1, Figure 2).
HYPOTENSION AND SYSTEMIC PERFUSION
Preterm infants with a mean arterial blood pressure lower
Figure 1.
Denition of hypotension by three pathophysiological
phenomena of increasing severity: the ‘autoregulatory, functional
and ischemic thresholds’ of hypotension. Cerebral cellular function
and structural integrity are not affected at the ‘autoregulatory
threshold’ and cerebral function becomes compromised at the
‘functional blood pressure threshold’ and finally, structural integrity is
compromised at the ‘ischemic blood pressure threshold’. Autore-
gulation is limited and ‘ischemic blood pressure threshold’, that
is likely to vary with the level of maturity, is unknown in preterm
infants. CBF, cerebral blood ow; MBP, mean blood pressure; CrCP,
critical closing pressure. From Cayabyab R, et al. J Perinatol 2009;
29:S58-62 [2].
101
Neonatal Med 2014 May;21(2):99-105
http://dx.doi.org/10.5385/nm.2014.21.2.99
than their gestational age in weeks often have no clinical signs of
shock, presumably have adequate tissue oxygen delivery, and may
therefore not need treatment
16)
.
The principal role of the circulation is to ensure adequate de
-
livery of oxygen and nutrients to tissues so that their metabolic
demand and is achieved by maintaining appropriate perfusion
pressure and cardiac output (CO) in the systemic and pulmonary
circulations demand
9)
. In the systemic circulation, the interaction
between CO and systemic vascular resistance (SVR) regulates BP
according to the relationship: BP=CO×SVR (Figure 3). However,
in clinical practice, we rely primarily on the information obtained
from BP monitoring and, at present, cannot routinely assess the
changes in CO and/or SVR when hypotension and/or cardio
-
vascular compromise are diagnosed and treated
10)
.
As maintenance of cardiovascular wellbeing is complicated,
neonatologists try to assess continuous heart rate, BP, arterial oxy-
gen saturation monitoring, and continuous CO monitoring with
or without assessment of the SVR together (Figure 3)
9)
. Under the
circumstance of neonatal shock, its early “compensated phase”
shows that blood flow and oxygen delivery are maintained to the
vital organs (brain, heart, and adrenal glands)
17)
. The vessels of
vital organs vasodilate when perfusion pressure decreases (high-
priority), whereas the vessels of non-vital organs respond with
vasoconstriction to a decrease in BP (low-priority). Recently, near
infrared spectroscopy (NIRS) can monitor, in real-time, the vital
and non-vital organ mixed venous tissue oxygen saturation
18)
.
Laboratory indices of perfusion, such as serum lactate and
acidosis (base excess) during anaerobic metabolism, frequently
used in the diagnosis of poor tissue perfusion (Table 1). Especially,
lactate values have been analyzed in a number of clinical situa
-
tions in the preterm infant and elevated values on the first
day of postnatal life are associated with increased mortality
in preterm and term newborns
19)
. In contrast, Wardle et al
20)
Figure 2.
Stress-velocity relationship [mVcfc (an index of LV pump
function) - ESWS (an index of LV afterload) relationship]. The
changes in mVcfc were opposite to the changes in ESWS. ere
were signicant correlations between ESWS and mVcfc in both
groups (mVcfc = 3.76×ESWS
-0.4
;
P
<0.01, R=0.56). Group 1: infants
with complications (pulmonary hemorrhage, intraventricular
hemorrhage, and periventricular leukomalacia; n=9). Group 2:
infants without complications (n=24). Systolic blood pressure
(sBP) and mean blood pressure (mBP) changed over time, with
no differences between the groups. This indicates that the LV
pump function of preterm infants can easily be suppressed by
a subtle increase in afterload, causing reduced cardiac output.
mVcfc, mean velocity of circumferential ber shortening; ESWS,
end-systolic wall stress; LV, left ventricle. From Toyoshima K, et
al. J Formos Med Assoc. 2013;112:510-7 [15].
Table 1.
Assessment of Cardiovascular Function and Organ Perfusion in Preterm Infants at the Bedside. From Toyoshima K, et al. J Formos
Med Assoc 2013;112:510-7 [15].
Vital signs HR, BP, urine
Blood examination lactic acid, BNP (brain natriuretic peptide), BE (base excess)
Echocardiography Preload
LVIDd (left ventricle internal diameter in diastole)
LA volume; LA (left atrium) / Ao (aorta)
Afterload
ESWS (end-systolic wall stress)
Pump function
EF (ejection fraction)
FS (fractional shortening)
mVcfc (mean velocity of circumferential ber shortening)
PDA : shunt assessment
Cardiac output : SVC (superior vena cava) ow
102
Hyun-Kyung Park
Hypotension in Preterm Infants
found no difference in lactate levels between normotensive
and hypotensive preterm infants. Correlation between lactate
values with systemic blood flow was improved by combining
capillary filling time; lactate >4 mmol/L plus prolonged capillary
refill times >4 s showed high positive predictive value (80%) and
negative predictive value (88%) for identifying low SVC ow. is
highlights the importance of combining clinical and biochemical
parameters in the assess
ment of the adequacy of end-organ blood
ow
8,9)
.
PERMISSIVE HYPOTENSION IN ELBW INFANTS
Global assessment of cardiovascular status includes assessment
of other easily evaluable physical observations including capillary
refill, skin color, heart rate, urine output, level of activity, and
biochemical observations, in particular the degree of acidosis
10)
.
Although this assessment of the adequacy of end-organ perfu
sion
is crude and not infallible, and each nding taken in isolation may
be a poor indicator of perfusion, together they may provide more
information than absolute blood pressure values alone. There is
no evidence that attempts to achieve a “normal” blood pressure
based on absolute reference values will improve out
comes, and
the therapies available may be potentially toxic or dangerous.
Dempsey et al
10)
evaluated this approach in ELBW infants in the
first 72 h of life and patients were grouped as either nor
motensive
(BP never less than gestational age), hypotensive untreated (BP
less than gestational age but with signs of good perfusion; we
termed this “permissive hypotension”), or hy
potensive treated
(BP less than gestational age with signs of poor perfusion). Blood
pressure spontaneously improved in ELBW infants during the rst
24 h and the outcome of infants hypotensive by gestational age
criteria but with clinical evidence of good perfusion was as good as
that of normotensive patients.
Figure 3.
Interaction among and monitoring of blood pressure (BP), blood ow, blood ow
distribution and systemic vascular resistance (SVR). To satisfy cellular metabolic demand, the
intricate relationship among blood ow, vascular resistance, and BP takes place. Regulation
of organ blood ow distribution, capillary recruitment and oxygen extraction is also essential
for the maintenance of hemodynamic homeostasis. Among these three fundamental
factors determining basic cardiovascular function, cardiac output (CO) and SVR are the
independent variables that are regulated by the body and BP is the dependent variable
by the two independent variables. Abbreviations: CBF, cerebral blood flow; NIRS, near
infrared spectroscopy; OBF, organ blood ow; rSO2, regional tissue oxygen saturation. From
Soleymani S, et al. J Perinatol 2010;30:S38-45 [9].
103
Neonatal Med 2014 May;21(2):99-105
http://dx.doi.org/10.5385/nm.2014.21.2.99
THERAPEUTIC APPROACHES TO HYPOTENSION
The stress-velocity relationship showed a steep slope in the low
ESWS range, as seen in Figure 2
15,21)
. e ESWS or afterload is lower
in younger age groups than in older age groups. Therefore, the
cardiac pumping function is easily impaired and mVcfc is easily
decreased by even a small increase in afterload or ESWS in smaller
or younger infants with low ESWS. All previous reports on the
stress-velocity relationship relate to preterm infants who were not
treated with circulatory agonists, and there have been no reports
on the changes in these parameters in preterm infants treated with
catecholamines.
Central venous pressure (CVP) monitoring is not practical in the
circulatory management of preterm infants. In CVP monitoring,
emphasis is placed largely on blood pressure. However, an
increase in cardiac preload or venous pressure due to excessive
afterload cannot be predicted by blood pressure or urine volume
alone
15)
. The aim of circulatory management in preterm infants
should be to avoid the increase in venous pressure caused by
excessive afterload.
Toyoshima et al
15)
investigated how circulatory agonists affect
excessive afterload and evaluated the changes in the stress-
velocity relationship prior to and after the use of dobutamine
and a vasodilator nitroglycerin in very low birth weight infants.
Dobutamine, at a dose of 4 mg
kg
-1
min
-1
, increased blood
pres sure in all infants. However, the stress-velocity relationship
showed that the cardiac pump function improved in only half
of the infants, whereas ESWS increased and cardiac pump
function deteriorated in the other half. Dobutamine did not
clearly improve low mVcfc, particularly when ESWS increased. By
contrast, a dose of 0.5-1.5 mg
kg
-1
min
-1
nitroglycerin, which
was used for elevated ESWS, reduced ESWS and increased mVcfc.
Dempsey et al
22)
recently established the HIP (Hypotension
in Preterm Infants) Consortium, comprising neonatologists,
scientists, pharmacologists and industry partners (Figure 4) to
provide assessment protocols for determining when we should
treat hypotension in the extremely preterm babies (< 28 weeks of
gestation) and in using the most commonly used dopamine.
Figure 4.
Treatment algorithm for the management of low BP in extremely preterm
infants during the rst 72 h of life; e HIP (hypotension in preterm infant) Trial. HIP
is designed to evaluate two strategies in a randomized controlled trial, and dene the
ecacy of the most commonly used inotropic medication, dopamine. From Dempsey EM,
et al. Neonatol 2014;105:275-81 [22].
104
Hyun-Kyung Park
Hypotension in Preterm Infants
CONCLUSION
In a neonatal intensive care setting, many extremely preterm
infants receive treatment for hypotension, but a blood pressure less
than the gestational age does not necessarily need to be treated.
Global assessment of cardiovascular status and intervention for
hypotension restricted to infants with poor perfusion (skin color,
capillary refill rate, urine output, blood lactate level, and acidosis)
may have good clinical outcomes
10,16,23)
. Prospective randomized
studies of clinical outcomes with standard versus restricted
treatment of hypotension are essential.
REFERENCES
1) Stranak Z, Semberova J, Barrington K, O'Donnell C, Marlow
N, Naulaers G, et al. International survey on diagnosis and
management of hypotension in extremely preterm babies.
Eur J Pediatr 2014 Jan 4. doi:10.1007/s00431-013-2251-9.
2) Cayabyab R, McLean CW, Seri I. Definition of hypotension
and assessment of hemodynamics in the preterm neonate. J
Perinatol 2009;29 Suppl 2:S58-62.
3) Batton B, Li L, Newman NS, Das A, Watterberg KL, Yoder BA,
et al. Use of antihypotensive therapies in extremely preterm
infants. Pediatrics 2013;131:e1865-73.
4) Osborn DA, Paradisis M, Evans N. The effect of inotropes on
morbidity and mortality in preterm infants with low systemic
or organ blood flow. Cochrane Database Syst Rev 2007:
CD005090. doi: 10.1002/14651858.CD005090.pub2.
5) Groves AM, Kuschel CA, Knight DB, Skinner JR. Relationship
between blood pressure and blood flow in newborn preterm
infants. Arch Dis Child Fetal Neonatal Ed 2008;93:F29-32.
6) Shah DM, Condò M, Bowen J, Kluckow M. Blood pressure or
blood flow: which is important in the preterm infant? a case
report of twins. J Paediatr Child Health 2012;48:E144-6.
7) Kluckow M, Evans N. Low superior vena cava flow and intra-
ventricular haemorrhage in preterm infants. Arch Dis Child
Fetal Neonatal Ed 2000;82:F188-94.
8) Miletin J, Dempsey EM. Low superior vena cava ow on day 1
and adverse outcome in the very low birthweight infant. Arch
Dis Child Fetal Neonatal Ed 2008;93:F368-71.
9) Soleymani S, Borzage M, Seri I. Hemodynamic monitoring in
neonates: advances and challenges. J Perinatol 2010;30 Suppl:
S38-45.
10) Dempsey EM, Al Hazzani F, Barrington KJ. Permissive hypo-
tension in the extremely low birthweight infant with signs of
good perfusion. Arch Dis Child Fetal Neonatal Ed 2009;94:
F241-4.
11) Azhan A, Wong FY. Challenges in understanding the impact of
blood pressure management on cerebral oxygenation in the
preterm brain. Front Physiol 2012;3:471. doi: 10.3389/fphys.
2012.00471.
12) Munro MJ, Walker AM, Barfield CP. Hypotensive extremely
low birth weight infants have reduced cerebral blood flow.
Pediatrics 2004;114:1591-6.
13) Tsuji M, Saul JP, du Plessis A, Eichenwald E, Sobh J, Crocker R,
et al. Cerebral intravascular oxygenation correlates with mean
arterial pressure in critically ill premature infants. Pediatrics
2000;106:625-32.
14) Greisen G. Autoregulation of cerebral blood flow in newborn
babies. Early Hum Dev 2005;81:423-8.
15) Toyoshima K, Kawataki M, Ohyama M, Shibasaki J, Yamaguchi
N, Hoshino R, et al. Tailor-made circulatory management based
on the stress-velocity relationship in preterm infants. J Formos
Med Assoc 2013;112:510-7.
16) Ahn SY, Kim ES, Kim JK, Shin JH, Sung SI, Jung JM, et al. Per-
missive hypotension in extremely low birth weight infants
(≤1000 gm). Yonsei Med J 2012;53:765-71.
17) Noori S, Stavroudis TA, Seri I. Systemic and cerebral hemody-
namics during the transitional period after premature birth.
Clin Perinatol 2009;36:723-36.
18) van Bel F, Lemmers P, Naulaers G. Monitoring neonatal regional
cerebral oxygen saturation in clinical practice: value and pitfalls.
Neonatology 2008;94:237-44.
19) Groenendaal F, Lindemans C, Uiterwaal CS, de Vries LS. Early
arterial lactate and prediction of outcome in preterm neonates
admitted to a neonatal intensive care unit. Biol Neonate 2003;
83:171-6.
20) Wardle SP, Yoxall CW, Weindling AM. Peripheral oxygenation
in hypotensive preterm babies. Pediatr Res 1999;45:343-9.
21) Takahashi Y, Harada K, Kishkurno S, Arai H, Ishida A, Takada
G. Postnatal left ventricular contractility in very low birth
weight infants. Pediatr Cardiol 1997;18:112-7.
22) Dempsey EM, Barrington KJ, Marlow N, O'Donnell CP, Miletin J,
Naulaers G, et al. Management of hypotension in preterm in-
fants (The HIP Trial): a randomised controlled trial of hypo-
tension management in extremely low gestational age new-
borns. Neonatology 2014;105:275-81.
23) Alderliesten T, Lemmers PM, van Haastert IC, de Vries LS, Bo-
nestroo HJ, Baerts W, et al. Hypotension in preterm neonates:
low blood pressure alone does not aect neurodevelopmental
outcome. J Pediatr 2014 Jan 28. doi: 10.1016/j.jpeds.2013.12.042.
105
Neonatal Med 2014 May;21(2):99-105
http://dx.doi.org/10.5385/nm.2014.21.2.99
미숙아에서의 적정 혈압
한양대학교 의과대학 소아과학교실
박현경
대부분의 신생아 의사들은 미숙아에서의 저혈압을 치료함에 있어, 재태기간 수치와 비교하여 그보다 낮은 평균 동맥압
보이는 경우를 대상으로 하지만, 진단 치료에 있어서는 모호한 상황이다. 저자는 심혈관계 생리를 근거로
미숙아에서의 permissive hypotension의 개념을 살펴보고, 혈압과 더불어 기관으로의 혈류 조직으로의 산소 전달
복잡한 관계를 규명할 있는 검사 방법 조직의 산소 요구량을 임상적 측면에서 검토하고자 한다. 절대적 혈압
수치는 단지 순환계 상태를 나타내는 하나의 지표에 지나지 않으며, 재태기간보다 낮은 평균 혈압으로는 예후를 예측
하지 못함을 강조한다. 포괄적인 심혈관계 상태의 판단 조직 관류 상태에 근거한 적절한 저혈압 치료만이 좋은 임상
경과를 나타낼 것으로 사료되며, 향후 심도있는 연구가 요구된다.
... Neonatal hypertension is identified when the systolic BP measured 3 times is higher than the 95th percentile in the BP classification by gestational age, birth weight, and sex. 6,7) The evaluation of hypotension in newborns is also important. Hypotension is identified when the systolic BP is less than the 5th-10th percentiles by gestational and postnatal age. ...
... Hypotension is identified when the systolic BP is less than the 5th-10th percentiles by gestational and postnatal age. 7) In extremely low birth weight infants, information on a normal BP is insufficient; therefore, mean arterial BP, which is lower than the newborn's gestational age in weeks, is clinically used as a treatment criterion. 7) In neonates, especially in cases of arterial catheterization through the umbilical artery, intra arterial BP through the catheter is the gold standard method for neonatal BP measurements. ...
... 7) In extremely low birth weight infants, information on a normal BP is insufficient; therefore, mean arterial BP, which is lower than the newborn's gestational age in weeks, is clinically used as a treatment criterion. 7) In neonates, especially in cases of arterial catheterization through the umbilical artery, intra arterial BP through the catheter is the gold standard method for neonatal BP measurements. 6,8) Neonatal movement, feeding, catheter position, and appropriate catheter size for the vessel Definition of hypertension in children ...
Article
Full-text available
A mercury sphygmomanometer (MS) has been the gold standard for pediatric blood pressure (BP) measurements, and diagnosing hypertension is critical. However, because of environmental issues, other alternatives are needed. Non-invasive BP measurement devices are largely divided into auscultatory and oscillometric types. The aneroid sphygmomanometer, the currently used auscultatory method, is inferior to mercury sphygmomanometers in terms of limitations such as validation and regular calibration and difficult to apply to infants, in whom Korotkoff sounds are not audible. The oscillometric method uses an automatic device that eliminates errors caused by human observers and has the advantage of being easy to use; however, owing to its measurement accuracy issues, the development of an international validation protocol for children is important. The hybrid method, which combines the auscultatory and electronic methods, solves some of these problems by eliminating the observer bias of terminal digit preference while maintaining measurement accuracy; however, the auscultatory method remains limited. As the age-related characteristics of the pediatric group are heterogeneous, it is necessary to reconsider the appropriate BP measurement method suitable for this indication. In addition, the mobile application-based BP measurement market is growing rapidly with the development of smartphone applications. Although more research is still needed on their accuracy, many experts expect that mobile application-based BP measurement will effectively reduce medical costs due to increased ease of access and early BP management.
... 18) Hypotension was defined as a mean blood pressure of <30 mmHg. 19) Neutropenia was defined as a neutrophil count of <1,000/μL. 20) Respiratory distress syndrome (RDS) was limited to the cases undergoing surfactant replacement treatments. ...
Article
Full-text available
Purpose: This study was undertaken to investigate the clinical features and prognostic factors of early-onset sepsis (EOS) in neonatal intensive care unit (NICU) patients. Methods: A retrospective analysis of the medical records was conducted in a NICU of a university hospital over a 7.5-year period (Jan 2010-Jun 2017). Results: During the study period, there were 45 (1.2%) episodes of EOS in 3,862 infants. The most common pathogen responsible for EOS was Streptococcus group B (GBS) in 10 cases (22.2%), followed by E. coli in 9 cases (20%). The frequency of Gram-positive sepsis was higher in term than in preterm infants, while the rate of Gram-negative infection was higher in preterm than in term infants (P<0.05). The overall mortality was 37.8% (17 of 45), and 47% of deaths occurred within the first 3 days of infection. There was a significant difference in terms of gestational age (26.8 weeks vs. 35.1 weeks) and birth weight (957 g vs. 2,520 g) between the death and survival groups. In a comparison after adjusting for the difference in gestational age and birth weight between the two groups, Gram-negative pathogens (OR: 42, 95% CI: 1.4~1281.8) and some clinical findings, such as neutropenia (OR: 46, 95% CI: 1.3~1628.7) and decreased activity (OR: 34, 95% CI: 1.8~633.4), were associated with fatality. Conclusion: The common pathogens responsible for EOS in NICU patients are GBS and E. coli. Infection caused by Gram-negative bacteria, decreased activity in the early phase of infection, and neutropenia were associated with poor outcomes.
... As a rough rule of thumb, the lower limit of normal mean BP on the day of birth, in mmHg, is approximately equal to the gestational age in weeks [2]. Low BP is considered hypotension, which needs to be treated if there are other signs of insufficient cardiac output like poor skin perfusion, metabolic acidosis, anuria and so on [3][4][5]. Neonatal hypertension has been found in 0.2-2.6% of neonatal intensive care survivors [6][7][8]. As there is dearth of studies reporting BP in healthy term and preterm neonates and as both genetic and environment factors may affect BP, we considered it worthwhile to determine the BP of healthy term and preterm Indian neonates rather than simply accepting Western data. ...
Article
Full-text available
Prospective observational study was conducted in a tertiary care hospital of India over 8 months to measure blood pressure (BP) in healthy term and preterm neonates using oscillometric method and explore the associations with gestational age and birth weight. Consecutive BP measurements were taken by standard oscillometric method on 1617 neonates on day 4, 7 and 14 of life. Mean birth weight was 2.7 ± 0.46 kg, and mean gestational age was 38.2 ± 2.12 weeks. The mean arterial pressure (MAP) on day 4, 7 and 14 were 59.3 ± 7.33, 63.2 ± 6.55 and 66.4 ± 6.13 mmHg, respectively. Larger and mature newborns had significantly higher BP than those who were smaller and premature. Birth weight more strongly correlated with MAP than gestational age. Predictive equations linking MAP with gestational age and birth weight were deduced, which can be used for judicious fluid inotrope management. © The Author [2015]. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Article
Full-text available
Mobile devices, TVs, and even houses are getting the "smart" treatment, and the demand for self-monitoring is growing. The Working Group of the European Society of Hypertension evaluates blood pressure measuring equipment in order to assist consumers in making informed decisions. This is the first independent device validation report. O'Brien and colleagues, 2001.) Smart blood pressure measurement devices are costly and slow, making them unsuitable for children. Because primary hypertension is more common in adolescents, it is more difficult to obtain products. Grewal, Mattoo, and Kapur, 2023. For the Internet of Things, a smart measuring tool for children's hypertension will be developed, allowing them to live a happy life free of their parents' worry and concern. Providing an IoT-based Smart Pediatric Hypertension System in order to reduce the number of deaths caused by delayed medical attention. IoT and Arduino are used to create a device that measures high blood pressure in children. The main idea is to control conventional hypertension measurement and obstacle detection using an Arduino microcontroller, GSM/GPS tool, blood pressure sensor, IFTTT platform, and lithium batteries. By developing an Internet of Things-based intelligent pediatric hypertension solution, this project aims to provide a profitable and full-time job with respectable employment for everyone, as well as promote balanced, equitable, and sustainable economic development. Comparisons between projects have been made to make selecting the right components easier. The critical components for the IoT-based Smart Pediatric Hypertension for Children alerting System will be identified, and the circuit design will be provided. Data on a variety of issues is collected using samples from hypertensive children aged 4 to 13. To provide accurate hypertension readings, compatibility and light components are used. Wi-Fi enabled Arduino Nano bracelet with blood pressure sensor, notification feature, IFTTT platform, GSM/GPS module, Lithium Batteries, and call and message warning.
Article
Full-text available
Hypotension is a commonly diagnosed and treated complication of extremely low gestational age newborns (ELGAN), but enormous variation in diagnosis, management and clinical practice has been documented. We sought to evaluate practice regarding the management of hypotension in ELGANs and developed a web-based questionnaire addressing diagnosis, intervention thresholds and modes of treatment of hypotension in ELGANs. We received 216 completed questionnaires from respondents in 38 countries. Most responses (83 %) were from specialist units where, together, over 26,000 very low birth weight (VLBW) infants are cared for annually. The majority (73 %) defined hypotension as a mean blood pressure (BP) in mmHg less than the gestational age in weeks. Sixty percent assessed the circulation with additional methods; echocardiography was the most commonly used (74 %), with left ventricular output and fractional shortening the two most common measurements made. The majority (85 %) used volume administration as the initial intervention. Dopamine was the inotrope most commonly used initially (80 %). If the initial inotrope therapy failed, dobutamine was the most popular second-line treatment (28 %). Delayed cord clamping was used at 51 % of the centres. Conclusion: The definition of hypotension in ELGANs continues to follow traditional standards. Functional echocardiography is now used to assess the circulation at many centres. Volume expansion and dopamine remain the most frequently used therapies. Electronic supplementary material The online version of this article (doi:10.1007/s00431-013-2251-9) contains supplementary material, which is available to authorized users.
Article
Full-text available
Background: Extremely preterm babies (delivered at <28 completed weeks of gestation) are frequently diagnosed with hypotension and treated with inotropic and pressor drugs in the immediate postnatal period. Dopamine is the most commonly used first-line drug. Babies who are treated for hypotension more frequently sustain brain injury, have long-term disability or die compared to those who are not. Despite the widespread use of drugs to treat hypotension in such infants, evidence for efficacy is lacking, and the effect of these agents on long-term outcomes is unknown. Hypothesis: In extremely preterm babies, restricting the use of dopamine when mean blood pressure (BP) values fall below a nominal threshold and using clinical criteria to determine escalation of support ('restricted' approach) will result in improved neonatal and longer-term developmental outcomes. RESEARCH PLAN: In an international multi-centre randomised trial, 830 infants born at <28 weeks of gestation, and within 72 h of birth, will be allocated to 1 of 2 alternative treatment options (dopamine vs. restricted approach) to determine the better strategy for the management of BP, using a conventional threshold to commence treatment. The first co-primary outcome of survival without brain injury will be determined at 36 weeks' postmenstrual age and the second co-primary outcome (survival without neurodevelopmental disability) will be assessed at 2 years of age, corrected for prematurity. Discussion: It is essential that appropriately designed trials be performed to define the most appropriate management strategies for managing low BP in extremely preterm babies.
Article
Full-text available
Preterm infants frequently experience pulmonary hemorrhage or cerebral intraventricular hemorrhage after birth. The immature myocardium of the left ventricle faces a high afterload after the baby is separated from the placenta. However, the preterm left ventricle has limited ability to respond to such an increase in afterload. This results in depressed cardiac function and a deterioration in hemodynamics. We speculated that the perinatal deterioration in cardiac performance would be closely related to serious hemorrhages. To prove our hypothesis, we studied the interrelationship between the perinatal changes in cardiac performance and the incidences of intraventricular and pulmonary hemorrhage. We obtained the stress-velocity relationship (rate-corrected mean fiber shortening velocity and end-systolic wall stress relationship) by M-mode echocardiography and arterial blood pressure measurement. We found that the incidences of intraventricular and/or pulmonary hemorrhages were higher in infants with an excessive afterload, which resulted in a decrease in the function of the left ventricle. We suggest that careful attention to keep the afterload at an acceptable level by vasodilator therapy and sedation may reduce or prevent these serious complications. In this review, we will discuss our data along with related literature.
Article
Full-text available
Systemic hypotension in preterm infants has been related to increased mortality, cerebrovascular lesions, and neurodevelopmental morbidity. Treatment of hypotension with inotropic medications aims at preservation of end organ perfusion and oxygen delivery, especially the brain. The common inotropic medications in preterm infants include dopamine, dobutamine, adrenaline, with adjunctive use of corticosteroids in cases of refractory hypotension. Whether maintenance of mean arterial blood pressure (MAP) by use of inotropic medication is neuroprotective or not remains unclear. This review explores the different inotropic agents and their effects on perfusion and oxygenation in the preterm brain, in clinical studies as well as in animal models. Dopamine and adrenalin, because of their α-adrenergic vasoconstrictor actions, have raised concerns of reduction in cerebral blood flow (CBF). Several studies in hypotensive preterm infants have shown that dopamine elevates CBF together with increased MAP, in keeping with limited cerebro-autoregulation. Adrenaline is also effective in raising cerebral perfusion together with MAP in preterm infants. Experimental studies in immature animals show no cerebro-vasoconstrictive effects of dopamine or adrenaline, but demonstrate the consistent findings of increased cerebral perfusion and oxygenation with the use of dopamine, dobutamine, and adrenaline, alongside with raised MAP. Both clinical and animal studies report the transitory effects of adrenaline in increasing plasma lactate, and blood glucose, which might render its use as a 2nd line therapy. To investigate the cerebral effects of inotropic agents in long-term outcome in hypotensive preterm infants, carefully designed prospective research possibly including preterm infants with permissive hypotension is required. Preterm animal models would be useful in investigating the relationship between the physiological effects of inotropes and histopathology outcomes in the developing brain.
Article
Full-text available
Purpose We performed this study to evaluate the safety of permissive hypotension management in extremely low birth weight infants (ELBWIs). Materials and Methods Medical records of all inborn ELBWIs admitted to Samsung Medical Center from January 2004 to December 2008 were reviewed retrospectively. Of a total of 261 ELBWIs, 47 (18%) required treatment for hypotension (group T), 110 (42%) remained normotensive (group N), and 104 (40%) experienced more than one episode of hypotension without treatment (group P) during the first 72 hours of life. Treatment of hypotension included inotropic support and/or fluid loading. Results Birth weight and Apgar scores were significantly lower in the T group than the other two groups. In the N group, the rate of pathologically confirmed maternal chorioamnionitis was significantly higher than other two groups, and the rate was higher in the P group than the T group. After adjusting for covariate factors, no significant differences in mortality and major morbidities were found between the N and P groups. However, the mortality rate and the incidence of intraventricular hemorrhage (≥stage 3) and bronchopulmonary dysplasia (≥moderate) were significantly higher in the T group than the other two groups. Long term neurodevelopmental outcomes were not significantly different between the N and P groups. Conclusion Close observation of hypotensive ELBWIs who showed good clinical perfusion signs without intervention allowed to avoid unnecessary medications and resulted in good neurological outcomes.
Article
Full-text available
Continuous, reliable and real-time assessment of major determinants of cardiovascular function in preterm and term neonates has long been an elusive aim in neonatal medicine. Accordingly, aside from continuous assessment of heart rate, blood pressure and arterial oxygen saturation, bedside monitoring of major determinants of cardiovascular function of significant clinical relevance such as cardiac output, systemic vascular resistance, organ blood flow distribution and tissue oxygen delivery and coupling has only recently become available. Without obtaining reliable information on the changes in and interactions among these parameters in the neonatal patient population during postnatal transition and later in the neonatal period, development of effective and less harmful treatment approaches to cardiovascular compromise is not possible. This paper briefly reviews the recent advances in our understanding of developmental cardiovascular physiology and discusses the methods of bedside assessment of cardiovascular function in general and organ perfusion, tissue oxygen delivery and brain function in particular in preterm and term neonates. The importance of real-time data collection and the need for meticulous validation of the methods recently introduced in the assessment of neonatal cardiovascular function such as echocardiography, electrical impedance cardiometry, near infrared spectroscopy, visible light and laser-Doppler technology are emphasized. A clear understanding of the accuracy, feasibility, reliability and limitations of these methods through thorough validation will result in the most appropriate usage of these methods in clinical research and patient care.
Article
Full-text available
The complexity of postnatal cardiovascular transition has only recently been better appreciated in the very low birth weight neonate. As blood pressure in itself poorly represents systemic blood flow, especially when the fetal channels are open and the developmentally regulated vital organ assignment may not have been completed, efforts to measure systemic blood flow have resulted in a novel, yet incomplete, understanding of the principles and clinical relevance of cardiovascular adaptation during postnatal transition in this patient population. This article describes the definition of hypotension based on the principles of cardiovascular physiology, and reviews the tools available to the clinician and researcher at the bedside to examine the complex relationship among blood pressure, systemic and organ blood flow, and tissue oxygen delivery and oxygen demand in vital and non-vital organs in the very low birth weight neonate. Only after gaining an insight into these complex relationships and processes will we be able to design clinical trials of selected treatment modalities targeting relevant patient sub-populations for the management of neonatal cardiovascular compromise. Only clinical trials based on a solid understanding of developmental cardiovascular physiology tailored to the appropriate patient sub-population hold the promise of being effective and practical, and can lead to improvements in both hemodynamic parameters and clinically relevant outcome measures.
Article
Autoregulation is a result of an intrinsic character of vascular smooth muscle cells. Other factors interact with pressure to define the degree of contraction of the smooth muscle cell. The final common pathway involves plasma membrane potassium conductance, smooth cell membrane potential, and cytoplasmatic calcium concentration. The molecular mechanisms are too complex to allow quantitative predictions. Autoregulation operates in most newborn infants (even the most immature), although the cerebral blood flow (CBF)-pressure relation is not likely to be strictly flat. In severely asphyxiated neonates, in preterm neonates who eventually develop major intracranial hemorrhage, and in hypotensive preterm infants treated with dopamine, the CBF-pressure relation is significantly above zero and may be as high as 4% per millimeter of mercury, corresponding to complete pressure passiveness. The lower threshold for cerebral autoregulation can be assumed to be 30 mm Hg or below. When blood pressure falls below this threshold, CBF decreases more than in proportion to pressure due to the elastic reduction in vascular diameter, but significant blood flow can be assumed to continue until the blood pressure is well below 20 mm Hg. The clinical relevance of autoregulation of CBF is the ability of cerebral arteries and arterioles to dilate to compensate for low blood pressure and protect against ischemic brain injury. The importance of the ability to constrict to protect against cerebral hemorrhage is not supported by clinical research.
Article
Objective: To investigate the relationships among blood pressure (BP) values, antihypotensive therapies, and in-hospital outcomes to identify a BP threshold below which antihypotensive therapies may be beneficial. Methods: Prospective observational study of infants 23(0/7) to 26(6/7) weeks' gestational age. Hourly BP values and antihypotensive therapy use in the first 24 hours were recorded. Low BP was investigated by using 15 definitions. Outcomes were examined by using regression analysis controlling for gestational age, the number of low BP values, and illness severity. Results: Of 367 infants enrolled, 203 (55%) received at least 1 antihypotensive therapy. Treated infants were more likely to have low BP by any definition (P < .001), but for the 15 definitions of low BP investigated, therapy was not prescribed to 3% to 49% of infants with low BP and, paradoxically, was administered to 28% to 41% of infants without low BP. Treated infants were more likely than untreated infants to develop severe retinopathy of prematurity (15% vs 8%, P = .03) or severe intraventricular hemorrhage (22% vs 11%, P < .01) and less likely to survive (67% vs 78%, P = .02). However, with regression analysis, there were no significant differences between groups in survival or in-hospital morbidity rates. Conclusions: Factors other than BP contributed to the decision to use antihypotensive therapies. Infant outcomes were not improved with antihypotensive therapy for any of the 15 definitions of low BP investigated.